Análisis de la acción Mesa Laboratories Inc (MLAB)MLABMesa Laboratories Inc

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring. It operates in the Healthcare sector (INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, A industry).

Mesa Laboratories Inc is a good buy right now due to its recent price increase of 3.47% over the last five days and a strong gross margin of 66.23% in Q4 2026, which suggests robust profitability. The current RSI of 83.95 indicates strong momentum, although it is approaching overbought territory. The main risk is the recent earnings miss, where revenue fell short by approximately $1.48 million, leading to a significant stock price drop of 19.5% following the Q4 report.

2 analysts cover MLAB: 1 rate it Buy, 1 Hold and 0 Sell. The average price target is 99.00.